Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder

NCT00395031 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Ziprasidone

Sponsor

Manhattan Psychiatric Center

Collaborators

[object Object]